This work was supported by the grants from the National Natural Science Foundation of China (No. 30400381);the "863"Program(No. 2001 AA215201).
Background Tuberculosis remains the leading cause of human death. Currently, Bacillus Calmette-Guerin (BCG) is the only available vaccine against tuberculosis but its efficacy is highly variable. Thus, developing ne...
This work was supported by a grant from the National Natural Science Foundation of China(No.30400381)
In an attempt to improve immune responses and protective efficacy, we constructed two recombinant bacille Calmette-Guérin (rBCG) strains expressing an 85B antigen (Ag85B) and early secreted antigenic target-6 kDa...